![Mark Neumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Neumann
Corporate Officer/Principal bij
VERADERMICS, INCORPORATED
Profiel
Mark Neumann is currently Chief Commercial & Strategy Officer at Veradermics, Inc. since 2025 and Chief Commercial Officer & Executive VP at Intra-Cellular Therapies, Inc. since 2018.
Formerly, Mr. Neumann was Vice President-Global Marketing at Amgen, Inc. from 2016 to 2018 and Vice President-Global Commercialization at Bristol Myers Squibb Co. from 2008 to 2014.
Education includes undergraduate studies at Lafayette College.
Actieve functies van Mark Neumann
| Bedrijven | Functie | Begin |
|---|---|---|
| VERADERMICS, INCORPORATED | Corporate Officer/Principal | 01-12-2025 |
Eerdere bekende functies van Mark Neumann
| Bedrijven | Functie | Einde |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Corporate Officer/Principal | 01-04-2025 |
| AMGEN INC. | Verkoop & Marketing | 01-09-2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-05-2014 |
Opleiding van Mark Neumann
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
95
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intra-Cellular Therapies, Inc.
 Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
